State Street’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-138,111
| Closed | -$7.3M | – | 3932 |
|
|
2020
Q3 | $7.3M | Buy |
138,111
+525
| +0.4% | +$32.4K | ﹤0.01% | 2608 |
|
|
2020
Q2 | $8.43M | Buy |
137,586
+2,309
| +2% | +$134K | ﹤0.01% | 2514 |
|
|
2020
Q1 | $7.65M | Sell |
135,277
-2,925
| -2% | -$167K | ﹤0.01% | 2425 |
|
|
2019
Q4 | $7.87M | Buy |
138,202
+7,327
| +6% | +$388K | ﹤0.01% | 2637 |
|
|
2019
Q3 | $7M | Buy |
130,875
+5,921
| +5% | +$345K | ﹤0.01% | 2631 |
|
|
2019
Q2 | $7.46M | Buy |
124,954
+7,101
| +6% | +$447K | ﹤0.01% | 2624 |
|
|
2019
Q1 | $7.35M | Buy |
117,853
+9,189
| +8% | +$608K | ﹤0.01% | 2590 |
|
|
2018
Q4 | $6.58M | Buy |
108,664
+4,279
| +4% | +$256K | ﹤0.01% | 2597 |
|
|
2018
Q3 | $6.11M | Buy |
104,385
+1,796
| +2% | +$91.6K | ﹤0.01% | 2763 |
|
|
2018
Q2 | $4.6M | Buy |
102,589
+3,222
| +3% | +$139K | ﹤0.01% | 2902 |
|
|
2018
Q1 | $4.41M | Buy |
99,367
+5,986
| +6% | +$251K | ﹤0.01% | 2863 |
|
|
2017
Q4 | $4.05M | Sell |
93,381
-1,779
| -2% | -$80K | ﹤0.01% | 2895 |
|
|
2017
Q3 | $4.43M | Sell |
95,160
-5,201
| -5% | -$249K | ﹤0.01% | 2857 |
|
|
2017
Q2 | $4.97M | Buy |
100,361
+11,271
| +13% | +$590K | ﹤0.01% | 2732 |
|
|
2017
Q1 | $4.88M | Buy |
89,090
+6,998
| +9% | +$370K | ﹤0.01% | 2705 |
|
|
2016
Q4 | $4.57M | Buy |
82,092
+5,981
| +8% | +$287K | ﹤0.01% | 2741 |
|
|
2016
Q3 | $3.47M | Buy |
76,111
+3,720
| +5% | +$149K | ﹤0.01% | 2757 |
|
|
2016
Q2 | $2.89M | Buy |
72,391
+388
| +0.5% | +$14.2K | ﹤0.01% | 2888 |
|
|
2016
Q1 | $2.51M | Buy |
72,003
+3,910
| +6% | +$143K | ﹤0.01% | 2908 |
|
|
2015
Q4 | $2.92M | Buy |
68,093
+9,973
| +17% | +$500K | ﹤0.01% | 2829 |
|
|
2015
Q3 | $2.53M | Buy |
58,120
+9,326
| +19% | +$503K | ﹤0.01% | 2895 |
|
|
2015
Q2 | $2.52M | Buy |
48,794
+8,546
| +21% | +$364K | ﹤0.01% | 2975 |
|
|
2015
Q1 | $1.58M | Buy |
40,248
+6,564
| +19% | +$257K | ﹤0.01% | 3109 |
|
|
2014
Q4 | $1.3M | Buy |
33,684
+2,283
| +7% | +$87.1K | ﹤0.01% | 3197 |
|
|
2014
Q3 | $1.11M | Buy |
+31,401
| New | +$922K | ﹤0.01% | 3227 |
|
Other funds holding BSTC
State Street's BSTC Position: Q4 2020 in Review
State Street sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 138,111 shares — an estimated $7.3M sold.
State Street first reported a position in BSTC in Q3 2014 and held it in 25 quarters. The position peaked at $8.43M in Q2 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- State Street reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- State Street sold 138,111 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $7.3M.
- State Street first reported a position in BioSpecifics Technologies Corp. in Q3 2014 and held it in 25 quarters.
- State Street's BioSpecifics Technologies Corp. position peaked at $8.43M in Q2 2020.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on State Street's 13F filing for Q4 2020, filed 16 Feb 2021.